The next thing I know, I’m waking up in a hospital bed with seven staples in my head and four stitches,” Bryan Kobel told The ...

Illegal from Russia, who drives for Uber, assaulted a Biotech CEO in April in downtown Charleston, South Carolina. Bryan ...

Biotech CEO Bryan Kobel sues Uber after illegal immigrant driver violently assaulted him in Charleston parking lot, leaving ...

Bryan Kobel, a biotech CEO, is suing Uber after allegedly being assaulted by a driver in Charleston. The driver, Vadim ...

A man is reportedly suing Uber after allegedly being punched and headbutted by a driver after he tried to bring his service dog along for the ride. A video captured the violent incident where a driver ...

Bryan Kobel is suing after allegedly being assaulted by an illegal immigrant Uber driver in Charleston, South Carolina. (The Law Offices of Kenneth Berger) ...

Biotech CEO Bryan Kobel described the aftermath of an illegal immigrant Uber attack that left him with a severe concussion in ...

Biotech CEO Gets Hands-On After Cyberattack to Protect Business Evotec’s Werner Lanthaler knew ransomware could easily spread, encrypting or exposing business partners’ data By Catherine Stupp ...

No work, no reading," Johnson told Time's Charlotte Alter. For context about his nighttime routine, the biotech CEO has said gets in bed by 8.30 p.m. and starts the day before 6 a.m.

Biotech-startup CEOs are taking more nuanced approaches to going public amid a downturn. Insider talked to the leaders of five privately held biotechs for their views on IPOs in 2023.

Sujal Patel, CEO of Nautilus Biotechnology Nautilus CEO Sujal Patel. (Nautilus Photo) Patel previously helped launch and lead Isilon Systems, which sold to EMC for $2.25 billion in 2010.

N/A = not available. As you can see, some biotech CEOs made off like Wall Street tycoons in 2014, although how they got paid and whether they deserved their pay are both up for debate.